Actively Recruiting
Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards
Led by Frieda Wolf · Updated on 2025-03-18
330
Participants Needed
1
Research Sites
498 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hypomagnesemia is a common entity in the inpatient and outpatient setting. in previous retrospective study hypomagnesemic patients have higher mortality and longer hospitalization. whether hypomagnesemia is merely a marker of poor prognosis, or whether replacing it can improve outcomes is unclear. The current standard of care is to discharge these patients without workup or further treatment, even if patients had received intravenous therapy while hospitalized. The investigator wish to examine prospectively whether giving replacement therapy affects mortality, length of hospital stay and overall well-being. In order to replete intracellular levels and replete magnesium stores, magnesium should be given for several months.
CONDITIONS
Official Title
Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is 18 years or older
- Patient has hypomagnesemia with magnesium level 1.9 mg/dL or lower
- Patient is admitted to internal medicine wards
- Patient is able to give informed consent
You will not qualify if you...
- Patient unable to give consent
- Patient admitted for an elective procedure
- Patient in critical condition or dying
- Advanced kidney disease with eGFR less than 15 ml/min or on dialysis
- Severe diarrhea preventing use of magnesium citrate
- Already receiving magnesium supplements
- Severe malnutrition or life-threatening hypomagnesemia (serum level less than 1 mg/dL) requiring intravenous and oral magnesium replacement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Emek Medical Center
Afula, Israel
Actively Recruiting
Research Team
F
Frieda Wolf
CONTACT
R
Rotem Shvartzman
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here